Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study

BACKGROUND: Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Med Biochem
Hauptverfasser: Marković, Danica, Jevtović-Stoimenov, Tatjana, Ćosić, Vladan, Stošić, Biljana, Dinić, Vesna, Marković-Živković, Bojana, Janković, Radmilo J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Sciendo 2018
Schlagworte:
Original Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294091/
https://ncbi.nlm.nih.gov/pubmed/30581346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jomb-2017-0046
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge